Alkoxypsoralens, novel nonpeptide blockers of Shaker-type K+ channels: Synthesis and photoreactivity

Journal of Medicinal Chemistry

Volumn 41, Issue 23, 1998, Pages 4542-4549

  Wulff, Heike ^a   Rauer, Heiko ^b   Düring, Tim ^a   Hanselmann, Christine ^b   Ruff, Katharina ^b   Wrisch, Anja ^b   Grissmer, Stephan ^b   Hänsel, Wolfram ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL BLOCKING AGENT; PSORALEN;

ARTEMIA; ARTICLE; DEMYELINATION; DNA MODIFICATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; PHOTOREACTIVITY; PHOTOTOXICITY; POTASSIUM CURRENT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; XENOPUS LAEVIS;

ANIMALS; ARTEMIA; AXONS; COUMARINS; DNA; DRUG EVALUATION, PRECLINICAL; OXYGEN; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PSORALENS; RANVIER'S NODES; SHAKER SUPERFAMILY OF POTASSIUM CHANNELS; ULTRAVIOLET RAYS; XENOPUS LAEVIS;

EID: 0032487929     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm981032o     Document Type: Article

References (61)

1. Hille, B. Ionic Channels of Excitable Membranes, 2nd ed.; Sinauer Associates: Sunderland, 1992.
2. Chandy, K. G.; Gutman, G. A. Voltage-Gated Potassium Channel Genes. In Handbook of Receptors and Channels; North, R. A., Ed.; CRC Press: Boca Raton, FL, 1995; pp 1-71.
3. Chiu, S. Y.; Ritchie, J. M. Evidence for the Presence of Potassium Channels in the Paranodal Region of Acutely Demyelinated Mammalian Single Nerve Fibres. J. Physiol. (London) 1981, 313, 415-437.
4. Waxman, S. G. Current Concepts in Neurology: Membranes, Myelin and the Pathophysiology of Multiple Sclerosis. N. Engl. J. Med. 1982, 306, 1529-1533.
5. Sherratt, R. M.; Bostock, H.; Sears, T. A. Effects of 4-Aminopyridine on Normal and Demyelinated Mammalian Nerve Fibres. Nature 1980, 283, 570-572.
6. van Diemen, H. A. M.; Polman, C. H.; van Dongen, T. M. M. M.; van Loenen, A. C.; Nauta, J. J. P.; Taphoon, M. J. B.; van Walbeck, H. K.; Koetsier, J. C. The Effects of 4-Aminopyridine on Clinical Signs in Multiple Sclerosis Patients. Results of a Randomized, Placebo-Controlled, Double-Blind, Crossover Study. Ann. Neurol. 1992, 32, 123-130.
7. Schwid, S. R.; Pebtrie, M. D.; McDermott, M. P.; Tierney, D. S.; Mason, D. H.; Goodman, A. D. Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis. Neurology 1997, 48, 817-821.
8. + Channels in Terminal and Juxtaparanodal Regions of Neurons. Nature 1993, 365, 75-79.
9. (b) Veh, R. W.; Lichtinghagen, R.; Sewing, S.; Wundern, F.; Grumbach, I. M.; Pongs, O. Immunohistochemical Localization of Five Members of the Kv1 Channel Subunits: Contrasting Subcellular Locations and Neuron-Specific Co-Localizations in Rat Brain. Eur. J. Neurosci. 1995, 7, 2189-2205.
10. + Channel a Subunit (Kv1.2) in the Rat Cerebellum. Eur. J. Neurosci. 1996, 8, 688-699.
11. Giovannoni, G.; Hartung, H. P. The Immunopathogenesis of Multiple Sclerosis and Guillain-Barré Syndrome. Curr. Opin. Neural. 1996, 9, 165-177.
12. Chandy, K. G.; DeCoursey, T. E.; Cahalan, M. D.; McLaughlin, C.; Gupta, S. Voltage-Gated Potassium Channels are Required for Human T Lymphocyte Activation. J. Exp. Med. 1984, 160, 369-385.
13. Lewis, R. S.; Cahalan, M. D. Potassium and Calcium Channels in Lymphocytes. Annu. Rev. Immunol. 1995, 13, 623-653.
14. DeCoursey, T. E.; Chandy, K. G.; Gupta, S.; Cahalan, M. D. Voltage-Gated Potassium Channels in Human T Lymphocytes: a Role in Mitogenesis? Nature 1984, 307, 465-467.
15. + Channel in Human T Lymphocytes. J. Physiol. (London) 1985, 358, 197-237.
16. Price, M.; Lee, S. C.; Deutsch, C. Charybdotoxin Inhibits Proliferation and Interleukin2 Production in Human Peripheral Blood Lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 10171-10175.
17. + Channels Depolarize Human T Lymphocytes: Mechanism of the Antiproliferative Effect of Charybdotoxin. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 10094-10098.
18. (161 Koo, G. C.; Blake, J. T.; Talento, A.; Nguyen, M.; Lin, S.; Sirotina, A.; Shah, K.; Mulvany, K.; Hora, J.; Cunnigham, P.; Wunderler, D.; McManus, O. B.; Slaugther, R.; Buiganesi, R.; Felix, J.; Garcia, M.; Williamson, J.; Kaczorowski, G.; Sigal, N.; Springer, M.; Feeney, W. Blockade of the Voltage Gated Potassium Channel Kvl.3 Inhibits Immune Responses In Vivo. J. Immunol. 1997, 158, 5120-5128.
19. Kaczorowski, G. J.; Koo, G. C. Lymphocyte Ion Channels as a Target for Immunosuppression. Perspecg. Drug Discovery Des. 1994, 2, 233-248.
20. Cahalan, M. D.; Chandy, K. G. Ion Channels in the Immune System as Targets for Immunosuppression. Curr. Opin. Biotechnol. 1997, 8, 749-756.
21. Bohuslavizki, K. H.; Hänsel, W.; Kneip, A.; Koppenhöfer, E.; Niemöller, E.; Sanmann, K. Mode of Action of Psoralens, Benzofurans, Acridinones and Coumarins on the Ionic Currents in Intact Myelinated Nerve Fibres and its Significance in Demyelinating Diseases. Gen. Physiol. Biophys. 1994, 13, 309-328.
22. Bohuslavizki, K. H.; Hinck-Kneip, C.; Kneip, A.; Koppenhöfer, E.; Reimers, A. Reduction of MS-Related Scotoma by a New Class of Potassium Channel Blockers from Ruta graveolens. Neuro-ophthalmology 1993, 13, 191-198.
23. van Iperen, H. P.; Beijersbergen van Henegouwen, G. M. J. Clinical and Mechanistic Aspects of Photopheresis. J. Photochem. Photobiol. B: Biol. 1997, 39, 99-109.
24. Gasparro, F. P. Psoralen DNA Photobiology; CRC Press: Bocca Raton, FL, 1988; Vol. I and II.
25. Averbeck, D. Recent Advances in Psoralen Phototoxicity Mechanism. Photochem. Photobiol. 1989, 50, 859-882.
26. Beijersbergen van Henegouwen, G. M. J.; Wijn, E. T.; Schoonderwoerd, S. A.; Dall'Acqua, F. Method for the Determination of the In Vivo Irreversible Binding of 8-Methoxypsoralen (8-MOP) to Epidermal Lipids, Proteins and DNA/RNA of Rats after PUVA Treatment. J. Photochem. Photobiol. B: Biol. 1989, 3, 631-635.
27. Zarebska, Z. Cell Membrane, a Target for PUVA Therapy. J. Photochem. Photobiol. B: Biol. 1994, 23, 101-109.
28. Zajdela, F.; Bisagni, E. 5-Methoxypsoralen, the Melanogenic Additive in Sun-Tan Preparations, is Tumorigenic in Mice exposed to 365 nm U.V. Radiation. Carcinogenesis 1981, 2, 121-127.
29. Kaufmann, H. D.; Kelly, R. C. A New Synthesis of Coumarins. J. Heterocycl. Chem. 1965, 2, 91-92.
30. Woods, L. L.; Shamma, S. M. Synthesis of Substituted Coumarins with Fluorescent Properties. J. Chem. Eng. 1971, 16, 101-102.
31. MacLeod, J. K.; Worth, B. R.; Wells, R. J. Synthesis of Benzofuranoid Systems IV: Total Synthesis of Cyperaquinone and Conicaquinone. Aust. J. Chem. 1978, 37, 1533-1544.
32. Heindel, N. D.; Foster, N.; Choudhuri, M. Transfer Hydrogenation of Furocoumarin Derivatives. J. Org. Chem. 1983, 48, 3817-3819.
33. Safranov, B. V.; Kampe, K.; Vogel, W. Single Voltage-Dependent Potassium Channels in Rat Peripheral Nerve Membrane. J. Physiol. (London) 1993, 460, 675-691.
34. + Channel in Xenopus Myelinated Nerve. J. Membr. Biol. 1996, 149, 221-232.
35. Bethge, E. W.; Bohuslavizki, K. H.; Hänsel, W.; Kneip, A.; Koppenhöfer, E. Effects of some Potassium Channel Blockers on the Ionic Currents in Myelinated Nerve. Gen. Physiol. Biophys. 1991, 10, 225-244.
36. Bohuslavizki, K. H.; Kneip, A.; Koppenhöfer, E. State-of-the-Art Potential Clamp Device for Myelinated Nerve Fibres Using a New Versatile Input Probe. Gen. Physiol. Biophys. 1994, 13, 357-376.
37. + Channels, Types Kv1.l, 1.2, 1.3, 1.5 and 3.1, Stably Expressed in Mammalian Cell Lines. Mol. Pharmacol. 1994, 45, 1227-1234.
38. Rauer, H.; Grissmer, S. Evidence for an Internal Phenylalkylamine Action on the Voltage-Gated Potassium Channel Kv1.3. Mol. Pharmacol. 1996, 50, 1625-1634.
39. Sage, E.; Moustacchi, E. Sequence Context Effects on 8-Methoxypsoralen Photobinding to Defined DNA Fragments. Biochemistry 1987, 26, 3307-3314.
40. Vedaldi, D.; Caffieri, S.; Frank, S.; Dall'Acqua, F.; Jakobs, A.; Piette, J. Sulphur and Selenium Analogues of Psoralen as Novel Potential Photochemotherapeutic Agents. Farmaco 1995, 50, 527-536.
41. Kraljic, I.; El Mohsni, S. A New Method for the Detection of Singlet Oxygen in Aqueous Solutions. Photochem. Photobiol. 1978, 28, 577-581.
42. -) by Psoralens and Ultraviolet Radiation (320-400 nm). Biochim. Biophys. Acta 1984, 798, 115-126.
43. Calleja, M. C.; Personne, G. Cyst-based Toxicity Tests IV. The Potential of Ecotoxicological Tests for the Prediction of Acute Toxicity in Man as Evaluated on the first ten Chemicals on the MEIC Programme. ATLA 1992, 20, 396-405.
44. (b) Calleja, M. C.; Personne, G.; Geladi, P. Comparative Acute Toxicity of the first 50 Multicentre Evaluation of In Vitro Cytotoxicity Chemicals to Aquatic Non-Vertebrates. Arch. Environ. Contam. Toxicol. 1994, 26, 69-78.
45. Matthews, R. S. Artemia salina as a Test Organism for Measuring Superoxid-Mediated Toxicity. Free Radicals Biol. Med. 1995, 18, 919-922.
46. Gonzalez, A. G.; Darias, V.; Boada, J. N.; Rodriguez-Luis, F. Cytostatic Activity of some Canary Islands Species of Rutaceae. Planta Medica 1977, 31, 351-357.
47. Gia, C.; Anselmo, A.; Conconi, M. T.; Antonello, C.; Uriarte, E.; Caffieri, S. 4′-Methyl Derivatives of 5-MOP and 5-MOA: Synthesis, Photoreactivity, and Photobiological Activity. J. Med. Chem. 1996, 39, 4489-4496.
48. +-Channel Blocking Psoralens Inhibit the Immune Response of Lymph Node Cells (LNC) of Lewis Rats with Experimental Autoimmune Encephalomyelitis (EAE). Eur. J. Neurosci. 1998, Suppl. 10, 164.
49. Ray, J. N.; Silooja, S. S.; Vaid, V. R. Experiments on the Synthesis of Bergapten and its Derivatives, Part I: Furocoumarins. J. Chem. Soc. 1935, 813-816.
50. Zagotto, G.; Gia, O.; Baccichetti, F.; Uriarte, E.; Palumbo, M. Synthesis and Photobiological Properties of 4-Hydroxymethyl-4′-methylpsoralen Derivatives. Photochem. Photobiol. 1993, 58, 480-491.
51. Schönberg, A.; Aziz, G. Furochromones and Coumarins. VI. Demethylation of Xanthotoxin, Khellin and Khellol with Aniline Hydrochloride and Magnesium Iodide. J. Am. Chem. Soc. 1953, 75, 3265-3266.
52. Abu-Mustafa, E. A.; El-Tawil, B. A. H.; Fayez, M. B. E. Natural coumarins: Part VIII -Some Reactions of Imperatorin and Related Products. Indian J. Chem. 1967, 5, 283-286.
53. Thoms, H.; Baetcke, E. Die Konstitution des Bergaptens. (On the Structure of Bergapten.) Ber. Dtsch. Chem. Ges. 1912, 45, 3705-3712.
54. Brokke, M. E.; Christensen, B. E. Psoralens II. Certain Reactions of Xanthotoxin. J. Org. Chem. 1959, 24, 523-526.
55. Abu-Shady, H. A.; Hassib, S. T.; Amin, K. M.; Farag, A. E. Synthesis of Some 9-Substitituted Psoralens for Screening of Photoactivity. Egypt. J. Pharm. Sci. 1991, 32, 61-73.
56. Foster, R. T.; Robertson, A. Furano-Compounds. Part VII. A Synthesis of 2:3-Dihydropsoralene. J. Chem. Soc. 1948, 2254-2259.
57. Thorns, H. Über die Konstitution des Xanthotoxins und seine Beziehungen zum Bergapten. (On the Structure of Xanthotoxin and its Relation to Bergapten.) Ber. Dtsch. Chem. Ges. 1911, 44, 3325.
58. Brokke, M. E.; Christensen, B. E. Psoralens I: Certain Reactions of Xanthotoxin. J. Org. Chem. 1958, 23, 589-595.
59. Isaacs, S. T.; Che-kun, J. S.; Hearst, J. E.; Rapoport, H. Synthesis and Characterization of New Psoralen Derivatives with Superior Photoreactivity with DNA and RNA. Biochemistry 1977, 16, 1058-1064.
60. Aboulezz, F.; El-Attar, A. A.; El-Sockary, M. A. Chloromethylation of Xanthotoxin and Dihydroxanthotoxin. Acta Chim. Acad. Sci. Hung. 1973, 77, 205.
61. Hansen, J. B.; Bjerring, P.; Burchardt, O.; Ebbesen, P.; Kanstrup, A.; Karup, G.; Knudsen, P.; Nielsen, P. E.; Norden, B.; Ygge, B. Psoralenamines 3: Synthesis, Pharmacological Behavior, and DNA Binding of 5-(Aminomethyl)-8-methoxy-, 5-[[(3-Aminopropyl)-oxy]methyl]-, and 8-[(3-Aminopropyl)-oxy]psoralen Derivatives. J. Med. Chem. 1985, 28, 1001-1010.